Cardiology Emergency Medicine Strong — Antman 2000; ESC ACS Guidelines 2023
TIMI Risk Score for UA/NSTEMI
7-point score predicting 14-day risk of all-cause mortality, new or recurrent MI, or severe recurrent ischaemia requiring revascularisation in UA/NSTEMI.
References
- Antman EM et al. The TIMI risk score for unstable angina/non-ST elevation MI. JAMA. 2000.
- ESC Guidelines for the management of acute coronary syndromes. Eur Heart J. 2023.
Related
Curated clinical cross-links plus same-class fallbacks.
Drugs
- Isosorbide Mononitrate (Stable Angina) · Nitrate / Stable Angina
- Nicorandil · Stable Angina
- Ranolazine · Refractory Stable Angina
- Glyceryl Trinitrate (Sublingual / IV) · Nitrate / Acute Angina
- Indocyanine Green (Intravitreal Chromovitrectomy) · Diagnostic Dye — Vitreoretinal Surgery / ICG Angiography
- Palivizumab · RSV Prophylaxis — Monthly Monoclonal Antibody (High-Risk Infants)
Pathways
- Acute Heart Failure · ESC 2021 Heart Failure Guidelines; NICE NG106
- NSTEMI / Unstable Angina · ESC 2020 NSTEMI Guidelines; NICE NG185
- New-Onset Atrial Fibrillation · ESC 2020 AF Guidelines; NICE NG196
- Hypertensive Emergency · ESC/ESH 2018 Hypertension Guidelines; NICE NG136
- Bradycardia Management · Resuscitation Council UK ABCDE; ESC 2021 Pacing Guidelines
- Ventricular Tachycardia / Fibrillation · Resuscitation Council UK ACLS; ESC 2022 Ventricular Arrhythmia Guidelines
Decision support only — verify against MDCalc, NICE, or your local guideline before clinical use.